# EDGAR Filing Document

**Accession Number:** 0001002427
**File Stem:** 0001410368-26-054423
**Filing Date:** 2026-5
**Character Count:** 44728
**Document Hash:** 199f67990f61aa92aa07a761dd93522c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-054423.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001410368-26-054423

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260528

**DATE AS OF CHANGE**: 20260528

**PERIOD START**: 20261231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Morgan Stanley Insight Fund
- **CENTRAL INDEX KEY:** 0001002427

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07377
- **FILM NUMBER:** 261030790

**BUSINESS ADDRESS:**
- **STREET 1:** C/O MORGAN STANLEY
- **STREET 2:** 1585 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 800-548-7786

**MAIL ADDRESS:**
- **STREET 1:** C/O MORGAN STANLEY
- **STREET 2:** 1585 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MORGAN STANLEY MULTI CAP GROWTH TRUST
- **DATE OF NAME CHANGE:** 20110331

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MORGAN STANLEY CAPITAL OPPORTUNITIES TRUST
- **DATE OF NAME CHANGE:** 20020129

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MORGAN STANLEY MID CAP EQUITY TRUST
- **DATE OF NAME CHANGE:** 20010618

## Series and Classes Contracts Data

### Morgan Stanley Insight Fund (Series ID: S000002337)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000006127 | A            | CPOAX           |
| C000006129 | L            | CPOCX           |
| C000006130 | I            | CPODX           |
| C000126925 | Class R6     | MCRTX           |
| C000155915 | Class C      | MSCMX           |
| C000216311 | Class IR     | MBIRX           |

## Nport-Ex

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited)

---

| | | |
|:---|:---|:---|
| **NUMBER OF<br> SHARES** |  | **VALUE** |
|  | **Common Stocks (85.7%)** |  |
|  | Automobiles (7.4%) |  |
| 223374 | Tesla, Inc. (a) | $83039284 |
|  | Biotechnology (7.7%) |  |
| 3833797 | Arbutus Biopharma Corp. (a) | 17252086 |
| 230242 | Immunovant, Inc. (a) | 5719211 |
| 1119402 | ProKidney Corp. (a) | 2003730 |
| 1926750 | Roivant Sciences Ltd. (a) | 53370975 |
| 252069 | XOMA Royalty Corp. (a) | 7907405 |
|  |  | 86253407 |
|  | Broadline Retail (2.7%) |  |
| 17297 | MercadoLibre, Inc. (a) | 29906859 |
|  | Capital Markets (0.8%) |  |
| 1347470 | Twenty One Capital, Inc., Class A (a)(b) | 8623808 |
|  | Electronic Equipment, Instruments & Components (0.0%) |  |
| 3889 | Magic Leap, Inc., Class A (acquisition cost — $1,890,214; acquired 12/22/15) (a)(c)(d) |  |
|  | Entertainment (4.6%) |  |
| 913686 | ROBLOX Corp., Class A (a) | 51678080 |
|  | Financial Services (8.3%) |  |
| 1106115 | Affirm Holdings, Inc. (a) | 50682189 |
| 5750796 | Federal National Mortgage Association (a) | 41750779 |
|  |  | 92432968 |
|  | Health Care Providers & Services (0.2%) |  |
| 321845 | Agilon health, Inc. (a) | 2545794 |
|  | Information Technology Services (18.0%) |  |
| 756018 | Cloudflare, Inc., Class A (a) | 155996754 |
| 386659 | Shopify, Inc., Class A (Canada) (a) | 45865491 |
|  |  | 201862245 |
|  | Personal Care Products (0.1%) |  |
| 113700 | Oddity Tech Ltd., Class A (Israel) (a) | 1521306 |
|  | Pharmaceuticals (7.3%) |  |
| 1714764 | Royalty Pharma PLC, Class A | 82257229 |
|  | Real Estate Management & Development (5.3%) |  |
| 12569205 | Opendoor Technologies, Inc. (a) | 58823879 |
|  | Software (13.4%) |  |
| 128092 | AppLovin Corp., Class A (a) | 50980616 |
| 9733307 | Aurora Innovation, Inc. (a) | 40101225 |
| 727931 | BitMine Immersion Technologies, Inc. | 14398475 |
| 116843 | Palantir Technologies, Inc., Class A (a) | 17091794 |
| 225226 | Strategy, Inc., Class A (a) | 28108205 |
|  |  | 150680315 |
|  | Tech Hardware, Storage & Peripherals (3.4%) |  |
| 1320108 | IonQ, Inc. (a) | 38058714 |
|  | Trading Companies & Distributors (6.5%) |  |
| 3739997 | QXO, Inc. (a) | 72630742 |
|  | **Total Common Stocks** *(Cost $812,391,117)* | 960314630 |
| **NUMBER OF<br> WARRANTS** |  |  |
|  | **Warrants (0.0%)‡** |  |
|  | Real Estate Management & Development (0.0%)‡ |  |
| 349131 | Opendoor Technologies, Inc. expires 11/20/26 (a) *(Cost $0)* | 126665 |

---

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

---

| | | |
|:---|:---|:---|
| **NUMBER OF<br> SHARES** |  | **VALUE** |
|  | **Preferred Stocks (7.6%)** |  |
|  | Software (7.6%) |  |
| 523556 | Databricks, Inc., Series H (a)(c)(d) (acquisition cost - $38,473,059; acquired 8/31/21) | $85056907 |
| 197427 | Lookout, Inc., Series F (a)(c)(d) (acquisition cost - $2,255,228; acquired 6/17/14) | 438288 |
|  | **Total Preferred Stocks** *(Cost $40,728,287)* | 85495195 |
|  | **Investment Company (2.2%)** |  |
| 626653 | iShares Bitcoin Trust ETF (a) *(Cost $24,247,899)* | 24076008 |
| **NUMBER OF<br> SHARES (000)** |  |  |
|  | **Short-Term Investments (5.3%)** |  |
|  | Investment Company (4.6%) |  |
| 51542 | Morgan Stanley Institutional Liquidity Funds — Treasury Securities Portfolio — Institutional Class, 3.52% (e)*<br> (Cost $51,541,769)* | 51541769 |
|  | **Securities held as Collateral on Loaned Securities (0.7%)** |  |
|  | Investment Company (0.5%) |  |
| 5519 | Morgan Stanley Institutional Liquidity Funds — Treasury Securities Portfolio — Institutional Class, (e) | 5518601 |
| **PRINCIPAL<br> AMOUNT<br> (000)** |  |  |
|  | *Repurchase Agreements (0.2%)* |  |
| 858 | Merrill Lynch & Co., Inc., (3.59%, dated 3/31/26, due 4/1/26; proceeds $858,373; fully collateralized by U.S. Government obligations; 0.00% - 1.00% due 11/15/27 - 7/31/28; valued at $875,202) | 858288 |
| 1743 | Merrill Lynch & Co., Inc., (3.66%, dated 3/31/26, due 4/1/26; proceeds $1,742,893; fully collateralized by U.S. Government obligations; 0.75% - 2.88% due 2/15/45 - 11/15/47; valued at $1,777,824) | 1742716 |
|  |  | 2601004 |
|  | **Total Securities held as Collateral on Loaned Securities** *(Cost $8,119,605)* | 8119605 |

---

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

---

| | | | |
|:---|:---|:---|:---|
| **PRINCIPAL<br> AMOUNT<br> (000)** |  | | **VALUE** |
|  | **Total Short-Term Investments** *(Cost $59,661,374)* |  | $59661374 |
|  | **Total Investments Excluding Purchased Options** *(Cost $937,028,677)* | 100.8% | 1129673872 |
|  | **Total Purchased Options Outstanding** *(Cost $6,689,002)* | 0.1% | 1168673 |
|  | **Total Investments** *(Cost $943,717,679)* including $7,994,688 of Securities Loaned (f)(g) | 100.9% | 1130842545 |
|  | **Liabilities in Excess of Other Assets** | (0.9) | (10605584) |
|  | **Net Assets** | 100.0% | $1120236961 |

---

---

| | |
|:---|:---|
| *‡* | *Amount is less than 0.05%.* |
| *(a)* | *Non-income producing security.* |
| *(b)* | *All or a portion of this security was on loan. The value of loaned securities and related collateral outstanding at March 31, 2026, were $7,994,688 and $8,119,605, respectively. The Fund received cash collateral of $8,119,605, which was subsequently invested in Repurchase Agreements and Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class as reported in the Consolidated Portfolio of Investments. The Fund has the right under the securities lending agreement to recover the securities from the borrower on demand.* |
| *(c)* | *Security cannot be offered for public resale without first being registered under the Securities Act of 1933 and related rules ("restricted security"). Acquisition date represents the day on which an enforceable right to acquire such security is obtained and is presented along with related cost in the security description. The Fund has registration rights for certain restricted securities. Any costs related to such registration are borne by the issuer. The aggregate value of restricted securities (excluding 144A holdings) at March 31, 2026 amounts to $85,495,195 and represents 7.6% of net assets.* |
| *(d)* | *Security is valued using significant unobservable inputs and is categorized as Level 3 in the fair value hierarchy.* |
| *(e)* | *The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - (the "Liquidity Fund"), an open-end management investment company managed by the Adviser, both directly and as a portion of the securities held as collateral on loaned securities. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Fund. For the three months ended March 31, 2026, advisory fees paid were reduced by $12,498 relating to the Fund's investment in the Liquidity Fund.* |
| *(f)* | *The Fund is permitted to purchase and sell securities ("cross-trade") from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Directors in compliance with Rule 17a-7 under the Act (the "Rule"). As a result of a change in the Rule 2a-5 (aka the "Valuation Rule"), which impacts transactions under Rule 17a-7, a security is an eligible security for purposes of Rule 17a-7 only when there is a "readily available market quotation" for the security. The Fund's Rule 17a-7 policy was amended effective September 8, 2022, to reflect the new requirements of Rule 2a-5. For the three months ended March 31, 2026, the Fund did not engage in any cross-trade transactions.* |
| *(g)* | *At March 31, 2026, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is approximately $361,938,619 and the aggregate gross unrealized depreciation is approximately $174,813,753, resulting in net unrealized appreciation of approximately $187,124,866.* |
| *ETF* | *Exchange Traded Fund.* |

---

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

**Call Options Purchased:**

The Fund had the following call options purchased open at March 31, 2026:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **COUNTERPARTY** | **DESCRIPTION** | **STRIKE<br> PRICE** | **EXPIRATION<br> DATE** | **NUMBER OF<br> CONTRACTS** | **NOTIONAL<br> AMOUNT<br> (000)** | **VALUE** | **PREMIUMS<br> PAID** | **UNREALIZED<br> DEPRECIATION** |
| Barclays Bank PLC | USD/CNH | CNH7.20 | Feb–27 | 472374137 | $472374 | $754854 | $1241117 | $(486263) |
| Standard Chartered Bank | USD/CNH | CNH7.32 | Dec–26 | 512895404 | 512895 | 384672 | 1451494 | (1066822) |
| Standard Chartered Bank | USD/CNH | CNH7.58 | Aug–26 | 468728898 | 468729 | 28592 | 1533646 | (1505054) |
| Goldman Sachs & Co. LLC | USD/CNH | CNH7.71 | May–26 | 332468224 | 332468 | 333 | 1383935 | (1383602) |
| Standard Chartered Bank | USD/CNH | CNH7.90 | Apr–26 | 222022032 | 222022 | 222 | 1078810 | (1078588) |
|  |  |  |  |  |  | $1168673 | $6689002 | $(5520329) |

---

CNH — Chinese Yuan Renminbi Offshore

USD — United States Dollar

**Consolidated Summary of Investments (unaudited)**

---

| | | |
|:---|:---|:---|
| **INDUSTRY †** | **VALUE** | **PERCENT OF<br> TOTAL<br> INVESTMENTS** |
| Software | $236175510 | 21.0% |
| Information Technology Services | 201862245 | 18.0 |
| Financial Services | 92432968 | 8.2 |
| Biotechnology | 86253407 | 7.7 |
| Automobiles | 83039284 | 7.4 |
| Pharmaceuticals | 82257229 | 7.3 |
| Investment Companies | 75617777 | 6.7 |
| Trading Companies & Distributors | 72630742 | 6.5 |
| Real Estate Management & Development | 58823879 | 5.3 |
| Entertainment | 51678080 | 4.6 |
| Tech Hardware, Storage & Peripherals | 38058714 | 3.4 |
| Broadline Retail | 29906859 | 2.7 |
| Capital Markets | 8623808 | 0.8 |
| Health Care Providers & Services | 2545794 | 0.2 |
| Personal Care Products | 1521306 | 0.1 |
| Purchased Options | 1168673 | 0.1 |
| Warrants | 126665 | 0.0 |
| Electronic Equipment, Instruments & Components |  | 0.0 |
| Total Investments | $1122722940 | 100.0% |

---

† Does not reflect the value of securities held as collateral on loaned securities. <br> †† Includes a security valued at zero.

Morgan Stanley Insight Fund

Notes to the Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited)

**A. Valuation of Investments —** (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges. If only bid prices are available then the latest bid price may be used. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers/dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (2) all other equity portfolio securities for which over-the-counter ("OTC") market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers/dealers; (3) when market quotations are not readily available, as defined by Rule 2a-5 under the Act, including circumstances under which Morgan Stanley Investment Management Inc. (the "Adviser"), a wholly-owned subsidiary of Morgan Stanley determines that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security's market value, portfolio securities are valued at their fair value as determined in good faith under procedures approved by and under the general supervision of the Fund's Board of Trustees (the "Trustees"). Each business day, the Fund uses a third-party pricing service approved by the Trustees to assist with the valuation of foreign equity securities. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that have a strong correlation to the fair-valued securities to more accurately reflect their fair value as of the close of regular trading on the NYSE; (4) foreign exchange transactions ("spot contracts") and foreign exchange forward contracts ("forward contracts") are valued daily using an independent pricing vendor at the spot and forward rates, respectively, as of the close of the NYSE; (5) listed options are valued at the last reported sales price on the exchange on which they are listed (or at the exchange official closing price if such exchange reports an official closing price). If an official closing price or last reported sales price is unavailable, the listed option should be fair valued at the mean between its latest bid and ask prices. Unlisted options are valued at the mean between their latest bid and ask prices from a reputable broker/dealer or valued by a pricing service/vendor; (6) fixed income securities may be valued by an outside pricing service/vendor approved by the Trustees. The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads and/or other market data and specific security characteristics. If the Adviser, a wholly-owned subsidiary of Morgan Stanley, determines that the price provided by the outside pricing service/vendor does not reflect the security's fair value or the pricing service/vendor or exchange is unable to provide a price, prices from reputable brokers/dealers may also be utilized. In these circumstances, the value of the security will be the mean of bid and asked prices obtained from reputable brokers/dealers; and (7) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value ("NAV") as of the close of each business day.

In connection with Rule 2a-5 of the Act, the Trustees have designated the Fund's Adviser as its valuation designee. The valuation designee has responsibility for determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Trustees. Under procedures approved by the Trustees, the Fund's Adviser, as valuation designee, has formed a Valuation Committee whose members are approved by the Trustees. The Valuation Committee provides administration and oversight of the Fund's valuation policies and procedures, which are reviewed at least annually by the Trustees. These procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

Morgan Stanley Insight Fund

Notes to the Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

**Fair Value Measurement:** Financial Accounting Standards Board ("FASB") ASC 820, "Fair Value Measurement" ("ASC 820"), defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs); and (2) inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in determining the value of the Fund's investments. The inputs are summarized in the three broad levels listed below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Level 1 – unadjusted quoted
prices in active markets for identical investments

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Level 2 – other significant
observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Level 3 – significant unobservable
inputs including the Fund's own assumptions in determining the fair value of investments. Factors considered in making this determination
may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for
exchange-traded securities), analysis of the issuer's financial statements or other available documents and, if necessary, available
information concerning other securities in similar circumstances.

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security.

Morgan Stanley Insight Fund

Notes to the Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

The following is a summary of the inputs used to value the Fund's investments as of March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **INVESTMENT TYPE** | **LEVEL 1<br> UNADJUSTED<br> QUOTED<br> PRICES** | **LEVEL 2<br> OTHER<br> SIGNIFICANT<br> OBSERVABLE<br> INPUTS** | **LEVEL 3<br> SIGNIFICANT<br> UNOBSERVABLE<br> INPUTS** | **TOTAL** |
| **Assets:** |  |  |  |  |
| **Common Stocks** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Automobiles | $83039284 | $— | $— | $83039284 |
| &nbsp;&nbsp;&nbsp;Biotechnology | 86253407 |  |  | 86253407 |
| &nbsp;&nbsp;&nbsp;Broadline Retail | 29906859 |  |  | 29906859 |
| &nbsp;&nbsp;&nbsp;Capital Markets | 8623808 |  |  | 8623808 |
| &nbsp;&nbsp;&nbsp;Electronic Equipment, Instruments & Components |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Entertainment | 51678080 |  |  | 51678080 |
| &nbsp;&nbsp;&nbsp;Financial Services | 92432968 |  |  | 92432968 |
| &nbsp;&nbsp;&nbsp;Health Care Providers & Services | 2545794 |  |  | 2545794 |
| &nbsp;&nbsp;&nbsp;Information Technology Services | 201862245 |  |  | 201862245 |
| &nbsp;&nbsp;&nbsp;Personal Care Products | 1521306 |  |  | 1521306 |
| &nbsp;&nbsp;&nbsp;Pharmaceuticals | 82257229 |  |  | 82257229 |
| &nbsp;&nbsp;&nbsp;Real Estate Management & Development | 58823879 |  |  | 58823879 |
| &nbsp;&nbsp;&nbsp;Software | 150680315 |  |  | 150680315 |
| &nbsp;&nbsp;&nbsp;Tech Hardware, Storage & Peripherals | 38058714 |  |  | 38058714 |
| &nbsp;&nbsp;&nbsp;Trading Companies & Distributors | 72630742 |  |  | 72630742 |
| **Total Common Stocks** | **960314630** | **—** | **—** | **960314630** |
| **Warrants** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Real Estate Management & Development | 126665 |  |  | 126665 |
| **Preferred Stocks** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Software |  |  | 85495195 | 85495195 |
| **Investment Company** | 24076008 |  |  | 24076008 |
| **Call Options Purchased** |  | 1168673 |  | 1168673 |
| **Short-Term Investments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Investment Company | 57060370 |  |  | 57060370 |
| &nbsp;&nbsp;&nbsp;Repurchase Agreements |  | 2601004 |  | 2601004 |
| **Total Short-Term Investments** | **57060370** | **2601004** | **—** | **59661374** |
| **Total Assets** | $**1041577673** | $**3769677** | $**85495195** | $**1130842545** |

---

*†* *Includes a security valued at zero.* 

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment's valuation changes.

Morgan Stanley Insight Fund

Notes to the Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value:

---

| | | |
|:---|:---|:---|
|  | **COMMON<br> STOCK** | **PREFERRED<br> STOCKS** |
| **Beginning Balance** | $— | $96939205 |
| &nbsp;&nbsp;&nbsp;Purchases |  |  |
| &nbsp;&nbsp;&nbsp;Sales |  |  |
| &nbsp;&nbsp;&nbsp;Transfers in |  |  |
| &nbsp;&nbsp;&nbsp;Transfers out |  |  |
| &nbsp;&nbsp;&nbsp;Corporate actions |  |  |
| &nbsp;&nbsp;&nbsp;Change in unrealized appreciation (depreciation) |  | (11444010) |
| &nbsp;&nbsp;&nbsp;Realized gains (losses) |  |  |
| **Ending Balance** | $— | $85495195 |
| Net change in unrealized appreciation (depreciation) from investments still held as of March 31, 2026 | $— | $(11444010) |

---

† Includes
a security valued at zero.

Morgan Stanley Insight Fund

Notes to the Consolidated Portfolio of Investments ■ March 31, 2026 (unaudited) *continued*

The following table presents additional information about valuation techniques and inputs used for investments that are measured at fair value and categorized within Level 3 as of March 31, 2026. Various valuation techniques were used in the valuation of certain investments and weighted based on the level of significance. The Fund calculated the weighted averages of the unobservable inputs relative to each investment's fair value as of March 31, 2026:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **FAIR VALUE AT<br> MARCH 31, 2026** | **VALUATION<br> TECHNIQUE** | **UNOBSERVABLE<br> INPUT** | **RANGE/<br> WEIGHTED AVERAGE** | **IMPACT TO<br> VALUATION FROM AN<br> INCREASE IN INPUT\*** |
| Preferred Stocks | $85495195 | Market Transaction Method | Precedent Transaction | $2.14-$190.00/$189.04 | Increase |
|  |  | Discounted Cash Flow | Weighted Average Cost of Capital | 10.5%-18.5%/11.5% | Decrease |
|  |  |  | Perpetual Growth Rate | 3.0%-4.0%/3.5% | Increase |
|  |  | Market Comparable Companies | Enterprise Value/Revenue | 2.6x-32.8x/17.8x | Increase |
|  |  |  | Discount for Lack of Marketability | 8.0%-18.0%/18.0% | Decrease |

---

*\** *Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.*

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Morgan Stanley Insight Fund

- **b. Investment Company Act file number:** 811-07377

- **c. CIK number of Registrant:** 0001002427

- **d. LEI of Registrant:** 54930088ZHK6FN0CHD61

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 1585 Broadway

  - **City:** NEW YORK

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10036

  - **Telephone number:** 800-869-6397

**Item A.2. Information about the Series.**

- **a. Name of Series:** Morgan Stanley Insight Fund

- **b. EDGAR series identifier (if any):** S000002337

- **c. LEI of Series:** 54930088ZHK6FN0CHD61

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-12-31

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1131191749.15

**Total Liabilities:** $11459346.52

**Net Assets:** $1119732402.63

**Amount of Assets Invested in Other Investment Companies:** $24075119.82

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000006127 | -7.62%               | -1.83%               | -4.88%               |
| Class ID C000006129 | -7.67%               | -1.86%               | -4.91%               |
| Class ID C000006130 | -7.61%               | -1.78%               | -4.87%               |
| Class ID C000126925 | -7.58%               | -1.80%               | -4.86%               |
| Class ID C000155915 | -7.63%               | -1.89%               | -4.95%               |
| Class ID C000216311 | -7.59%               | -1.79%               | -4.86%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $30661527.24             | $-132267762.04                             |
| Month 2  | $12423924.47             | $-34210453.11                              |
| Month 3  | $15020769.34             | $-71662135.01                              |

**Designated Index Information**

- **Index Name:** Securities Portfolio

- **Index Identifier:** SEC_PORT

### Schedule of Portfolio Investments

| Name                                               | Title                                                                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Affirm Holdings Inc                                | Affirm Holdings Inc                                                          | CUSIP: 00827B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1106115 | NS      | $50682189.30  | 4.53%             |  |  |  | No            |                  1 | On Loan: No      |
| agilon health Inc                                  | agilon health Inc                                                            | CUSIP: 00857U206<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    321845 | NS      | $2545793.95   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| AppLovin Corp                                      | AppLovin Corp                                                                | CUSIP: 03831W108<br>LEI: 549300LLVXMUAOL3SQ07 | Long             | EC               | CORP              | US        |    128092 | NS      | $50980616.00  | 4.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp                             | Arbutus Biopharma Corp                                                       | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |   3833797 | NS      | $17252086.50  | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Aurora Innovation Inc                              | Aurora Innovation Inc                                                        | CUSIP: 051774107<br>LEI: 984500AB2E0D9F7D9D76 | Long             | EC               | CORP              | US        |   9733307 | NS      | $40101224.84  | 3.58%             |  |  |  | No            |                  1 | On Loan: No      |
| BitMine Immersion Technologies Inc                 | BitMine Immersion Technologies Inc                                           | CUSIP: 09175A206<br>LEI: 254900TGJJ1D9JNAQT27 | Long             | EC               | CORP              | US        |    727931 | NS      | $14398475.18  | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Cloudflare Inc                                     | Cloudflare Inc                                                               | CUSIP: 18915M107<br>LEI: 5493007DY18BGNLDWU14 | Long             | EC               | CORP              | US        |    756018 | NS      | $155996754.12 | 13.93%            |  |  |  | No            |                  1 | On Loan: No      |
| Fannie Mae                                         | Fannie Mae Pool                                                              | CUSIP: 313586109<br>LEI: B1V7KEBTPIMZEU4LTD58 | Long             | EC               | USGSE             | US        |   5750796 | NS      | $41750778.96  | 3.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                                     | Immunovant Inc                                                               | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    230242 | NS      | $5719211.28   | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| IonQ Inc                                           | IonQ Inc                                                                     | CUSIP: 46222L108<br>LEI: 529900RB2VEFGLQS7G28 | Long             | EC               | CORP              | US        |   1320108 | NS      | $38058713.64  | 3.40%             |  |  |  | No            |                  1 | On Loan: No      |
| iShares Bitcoin Trust ETF                          | iShares Bitcoin Trust ETF                                                    | CUSIP: 46438F101<br>LEI: 529900HVFN08L8P4H851 | Long             | EC               | RF                | US        |    626653 | NS      | $24076008.26  | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| MercadoLibre Inc                                   | MercadoLibre Inc                                                             | CUSIP: 58733R102<br>LEI: 549300DKPDN9M5S8GB14 | Long             | EC               | CORP              | US        |     17297 | NS      | $29906858.94  | 2.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Strategy Inc                                       | Strategy Inc                                                                 | CUSIP: 594972408<br>LEI: 549300WQTWEJUEHXQX21 | Long             | EC               | CORP              | US        |    225226 | NS      | $28108204.80  | 2.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Opendoor Technologies Inc                          | Opendoor Technologies Inc                                                    | CUSIP: 683712103<br>LEI: 254900KX11YZ4HV5BQ47 | Long             | EC               | CORP              | US        |  12569205 | NS      | $58823879.40  | 5.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Opendoor Technologies Inc                          | Opendoor Technologies Inc                                                    | CUSIP: 683712129<br>LEI: 254900KX11YZ4HV5BQ47 | N/A              | DE               |  | US        |    116377 | NS      | $70640.84     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Opendoor Technologies Inc                          | Opendoor Technologies Inc                                                    | CUSIP: 683712137<br>LEI: 254900KX11YZ4HV5BQ47 | N/A              | DE               |  | US        |    116377 | NS      | $28628.74     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Opendoor Technologies Inc                          | Opendoor Technologies Inc                                                    | CUSIP: 683712145<br>LEI: 254900KX11YZ4HV5BQ47 | N/A              | DE               |  | US        |    116377 | NS      | $27395.15     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Palantir Technologies Inc                          | Palantir Technologies Inc                                                    | CUSIP: 69608A108<br>LEI: 549300UVN46B3BBDHO85 | Long             | EC               | CORP              | US        |    116843 | NS      | $17091794.04  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| ProKidney Corp                                     | ProKidney Corp                                                               | CUSIP: 74291D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1119402 | NS      | $2003729.58   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| ROBLOX Corp                                        | ROBLOX Corp                                                                  | CUSIP: 771049103<br>LEI: 529900ANZDBDFU91SO19 | Long             | EC               | CORP              | US        |    913686 | NS      | $51678080.16  | 4.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Shopify Inc                                        | Shopify Inc                                                                  | CUSIP: 82509L107<br>LEI: 549300HGQ43STJLLP808 | Long             | EC               | CORP              | CA        |    386659 | NS      | $45865490.58  | 4.10%             |  |  |  | No            |                  1 | On Loan: No      |
| QXO Inc                                            | QXO Inc                                                                      | CUSIP: 82846H405<br>LEI: 549300HDXQWWCBOYXP31 | Long             | EC               | CORP              | US        |   3739997 | NS      | $72630741.74  | 6.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Tesla Inc                                          | Tesla Inc                                                                    | CUSIP: 88160R101<br>LEI: 54930043XZGB27CTOV49 | Long             | EC               | CORP              | US        |    223374 | NS      | $83039284.50  | 7.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Twenty One Capital Inc                             | Twenty One Capital Inc                                                       | CUSIP: 90138L109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1347470 | NS      | $8623808.00   | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Morgan Stanley & Co. LLC                           | Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio | CUSIP: 61747C525<br>LEI: 549300OJY9IZ31SGS926 | Long             | STIV             | RF                | US        |   5518601 | NS      | $5518601.15   | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| SWAPS BARCLAYS BOC                                 | SWAPS BARCLAYS BOC                                                           | CUSIP: 000000000<br>LEI: N/A                  | Short            | STIV             | CORP              | US        |   -960000 | NS      | $-960000.00   | -0.09%            |  |  |  | No            |                  2 | On Loan: No      |
| DATABRICKS, INC. SERIES H PREFERRED SHARES         | DATABRICKS, INC. SERIES H PREFERRED SHARES                                   | CUSIP: 000000000<br>LEI: 984500FEDAC7FBD96273 | Long             | EP               | CORP              | US        |    523556 | NS      | $85056907.76  | 7.60%             |  |  |  | No            |                  3 | On Loan: No      |
| MAGIC LEAP CL A COMMON                             | MAGIC LEAP CL A COMMON                                                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3889 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Morgan Stanley & Co. LLC                           | Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio | CUSIP: 61747C525<br>LEI: 549300OJY9IZ31SGS926 | Long             | STIV             | RF                | US        |  51541769 | NS      | $51541769.16  | 4.60%             |  |  |  | No            |                  1 | On Loan: No      |
| XOMA Royalty Corp                                  | XOMA Royalty Corp                                                            | CUSIP: 98419J206<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    252069 | NS      | $7907404.53   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| SWAP STAND. CHARTER BANK BOCOC                     | SWAP STAND. CHARTER BANK BOCOC                                               | CUSIP: 000000000<br>LEI: N/A                  | Short            | STIV             | CORP              | US        |   -740000 | NS      | $-740000.00   | -0.07%            |  |  |  | No            |                  2 | On Loan: No      |
| SWAP GOLDMAN SACHS BOC                             | SWAP GOLDMAN SACHS BOC                                                       | CUSIP: 000000000<br>LEI: N/A                  | Short            | STIV             | CORP              | US        |   -170000 | NS      | $-170000.00   | -0.02%            |  |  |  | No            |                  2 | On Loan: No      |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | MERRILL LYNCH TRI PARTY A REPO                                               | CUSIP: 000000000<br>LEI: 8NAV47T0Y26Q87Y0QP81 | Long             | RA               | CORP              | US        |    858288 | PA      | $858287.70    | 0.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | MERRILL LYNCH TRI PARTY A REPO                                               | CUSIP: 000000000<br>LEI: 8NAV47T0Y26Q87Y0QP81 | Long             | RA               | CORP              | US        |   1742716 | PA      | $1742716.15   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| LOOKOUT INC SER F CVT PFD PP                       | LOOKOUT INC SER F CVT PFD PP                                                 | CUSIP: 000000000<br>LEI: 5493001FMB46AJ886C96 | Long             | EP               | CORP              | US        |    197427 | NS      | $438287.94    | 0.04%             |  |  |  | No            |                  3 | On Loan: No      |
| Standard Chartered Bank                            | CNHP25303 USD CALL/CNH PUT                                                   | CUSIP: 000000000<br>LEI: RILFO74KP1CM8P6PCT96 | N/A              | DFE              |  | US        | 222022032 | OU      | $222.02       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Goldman Sachs & Co. LLC                            | CNHP33544 USD CALL/CNH PUT                                                   | CUSIP: 000000000<br>LEI: FOR8UP27PHTHYVLBNG30 | N/A              | DFE              |  | US        | 332468224 | OU      | $332.47       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Standard Chartered Bank                            | CNHP25302 USD CALL/CNH PUT                                                   | CUSIP: 000000000<br>LEI: RILFO74KP1CM8P6PCT96 | N/A              | DFE              |  | US        | 468728898 | OU      | $28592.46     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Standard Chartered Bank                            | CNHP66560 USD CALL/CNH PUT                                                   | CUSIP: 000000000<br>LEI: RILFO74KP1CM8P6PCT96 | N/A              | DFE              |  | US        | 512895405 | OU      | $384671.55    | 0.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Barclays Bank PLC                                  | CNHP23613 USD CALL / CNH PUT                                                 | CUSIP: 000000000<br>LEI: G5GSEF7VJP5I7OUK5573 | N/A              | DFE              |  | US        | 472374137 | OU      | $754853.87    | 0.07%             |  |  |  | No            |                  2 | On Loan: No      |
| Roivant Sciences Ltd                               | Roivant Sciences Ltd                                                         | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |   1926750 | NS      | $53370975.00  | 4.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                                 | Royalty Pharma PLC                                                           | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |   1714764 | NS      | $82257229.08  | 7.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Oddity Tech Ltd                                    | Oddity Tech Ltd                                                              | CUSIP: 000000000<br>LEI: 254900QH12XZS53G0V57 | Long             | EC               | CORP              | IL        |    113700 | NS      | $1521306.00   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-04-28

**Name of Applicant:** Morgan Stanley Insight Fund

**Signature:** James F. Kirchner

**Name of Signer:** James F. Kirchner

**Title:** Principal Financial Officer